Cargando…
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794587/ https://www.ncbi.nlm.nih.gov/pubmed/35098127 http://dx.doi.org/10.1093/noajnl/vdac011 |
| _version_ | 1784640846168064000 |
|---|---|
| author | Song, Andrew J Ding, Keyue Alnahhas, Iyad Laperriere, Normand J Perry, James Mason, Warren P Winch, Chad O’Callaghan, Chris J Menten, Johan J Brandes, Alba A Phillips, Claire Fay, Michael F Nishikawa, Ryo Osoba, David Cairncross, J Gregory Roa, Wilson Wick, Wolfgang Shi, Wenyin |
| author_facet | Song, Andrew J Ding, Keyue Alnahhas, Iyad Laperriere, Normand J Perry, James Mason, Warren P Winch, Chad O’Callaghan, Chris J Menten, Johan J Brandes, Alba A Phillips, Claire Fay, Michael F Nishikawa, Ryo Osoba, David Cairncross, J Gregory Roa, Wilson Wick, Wolfgang Shi, Wenyin |
| author_sort | Song, Andrew J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8794587 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87945872022-01-28 Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial Song, Andrew J Ding, Keyue Alnahhas, Iyad Laperriere, Normand J Perry, James Mason, Warren P Winch, Chad O’Callaghan, Chris J Menten, Johan J Brandes, Alba A Phillips, Claire Fay, Michael F Nishikawa, Ryo Osoba, David Cairncross, J Gregory Roa, Wilson Wick, Wolfgang Shi, Wenyin Neurooncol Adv Corrigendum Oxford University Press 2022-01-27 /pmc/articles/PMC8794587/ /pubmed/35098127 http://dx.doi.org/10.1093/noajnl/vdac011 Text en © The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Corrigendum Song, Andrew J Ding, Keyue Alnahhas, Iyad Laperriere, Normand J Perry, James Mason, Warren P Winch, Chad O’Callaghan, Chris J Menten, Johan J Brandes, Alba A Phillips, Claire Fay, Michael F Nishikawa, Ryo Osoba, David Cairncross, J Gregory Roa, Wilson Wick, Wolfgang Shi, Wenyin Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial |
| title | Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial |
| title_full | Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial |
| title_fullStr | Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial |
| title_full_unstemmed | Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial |
| title_short | Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial |
| title_sort | corrigendum to: impact of lymphopenia on survival for elderly patients with glioblastoma: a secondary analysis of the cctg ce.6 (eortc 26062-22061, trog 08.02) randomized clinical trial |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794587/ https://www.ncbi.nlm.nih.gov/pubmed/35098127 http://dx.doi.org/10.1093/noajnl/vdac011 |
| work_keys_str_mv | AT songandrewj corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT dingkeyue corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT alnahhasiyad corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT laperrierenormandj corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT perryjames corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT masonwarrenp corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT winchchad corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT ocallaghanchrisj corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT mentenjohanj corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT brandesalbaa corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT phillipsclaire corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT faymichaelf corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT nishikawaryo corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT osobadavid corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT cairncrossjgregory corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT roawilson corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT wickwolfgang corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial AT shiwenyin corrigendumtoimpactoflymphopeniaonsurvivalforelderlypatientswithglioblastomaasecondaryanalysisofthecctgce6eortc2606222061trog0802randomizedclinicaltrial |